Ann Faerden

Dr. Ann Faerden


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2009 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
AFAnn Faerden
Ann Faerden
AVAnja Vaskinn
Anja Vaskinn
AFArnstein Finset
Arnstein Finset
IAIngrid Agartz
Ingrid Agartz
EBElizabeth Ann Barrett
Elizabeth Ann Barrett
IMIngrid Melle
Ingrid Melle
The underlying nature of negative symptoms in psychosis is poorly understood. Investigation of the relationship between the different negative subsymptoms and neurocognition is one approach to understand more of the underlying nature. Apathy, one of the subsymptoms, is also a common symptom in other brain disorders. Its association with neurocognition, in particular executive functioning, is well documented in other brain disorders, but only studied in one former study of chronic patients with schizophrenia. This study investigates the association between apathy and neurocognitive functioning in patients with first episode psychosis (FEP), with the hypothesis that apathy is more associated with tests representing executive function than tests representing other neurocognitive domains. Seventy-one FEP patients were assessed with an extensive neuropsychological test battery. Level of apathy was assessed with the abridged Apathy Evaluation Scale (AES-C-Apathy). AES-C-Apathy was only significantly associated with tests from the executive domain [Semantic fluency (r = .37, p < .01), Phonetic fluency (r = .25, p < .05)] and working memory [Letter Number Span (r = .26; p =< .05)]; the first two representing the initiation part of executive function. Confounding variables such as co-occuring depression, positive symptoms or use of antipsychotic medication did not significantly influence the results. We replicated in FEP patients the relationship between apathy and executive functioning reported in another study for chronic patients with schizophrenia. We also found apathy in FEP to have the same relationship to executive functioning, as assessed with the Verbal fluency tests, as that reported in patients with other brain disorders, pointing to a common underlying nature of this symptom across disorders.

1 January 2010 in Schizophrenia Research
Verified
Journal Article
Closed access
AFAnn Faerden
Ann Faerden
AFArnstein Finset
Arnstein Finset
SFSvein Friis
Svein Friis
IAIngrid Agartz
Ingrid Agartz
EBElizabeth Ann Barrett
Elizabeth Ann Barrett
IMIngrid Melle
Ingrid Melle

1 January 2008 in European Psychiatry
Verified
Journal Article
Closed access
AFAnn Faerden
Ann Faerden
RNRagnar Nesvåg
Ragnar Nesvåg
EBElizabeth Ann Barrett
Elizabeth Ann Barrett
IAIngrid Agartz
Ingrid Agartz
AFArnstein Finset
Arnstein Finset
IMIngrid Melle
Ingrid Melle
Background: Recently there has been a renewed interest in defining the boundaries and subdomains of the negative syndrome in schizophrenia and new scales have been asked for. Apathy is one of the symptoms in focus. The Apathy Evaluation Scale (AES) with its clinical version (AES-C) is one of the most used scales in an interdisciplinary context, but it has never previously been used in a population with first episode psychosis. The main aims of this study were to examine the psychometric properties of the AES-C and its relationship to the Positive and Negative Syndrome Scale (PANSS).Methods: A total of 104 patients with first episode psychosis from the ongoing Thematic Organized Psychosis Research (TOP) study were included.Results: A factor analysis of the AES-C identified three subscales: Apathy, Insight and Social Contacts. Only the Apathy subscale showed satisfactory psychometric properties and showed acceptable convergent and discriminate properties by correlating strongly with the apathy-related items of the PANSS.Conclusions: This study shows that the AES-C measures more than one dimension. The main factor, the Apathy subscale, can however be used to assess apathy in first episode psychosis patients in the ongoing work of refining the subdomains of the negative syndrome.

1 November 2013 in Psychiatry Research
Verified
Journal Article
Closed access
AFAnn Faerden
Ann Faerden
EBElizabeth Ann Barrett
Elizabeth Ann Barrett
RNRagnar Nesvåg
Ragnar Nesvåg
SFSvein Friis
Svein Friis
AFArnstein Finset
Arnstein Finset
IMIngrid Melle
Ingrid Melle

1 December 2016 in Schizophrenia Research
Verified
Journal Article
Open access
MNMari Nerhus
Mari Nerhus
ABAkiah O. Berg
Akiah O. Berg
LKLevi R. Kvitland
Levi R. Kvitland
IDIngrid Dieset
Ingrid Dieset
SHSigrun Hope
Sigrun Hope
IMIngrid Melle
Ingrid Melle
There are indications that low S-25(OH)D is associated with increased disease severity in psychotic disorder. Our first aim was to investigate the relations between low S-25(OH)D and positive, negative and depressive symptoms. Our second aim was to explore if associations between S-25(OH)D and symptoms were influenced by levels of inflammatory markers. Participants (N=358) with a medical history of one or more psychotic episodes were recruited. Current symptomatology was assessed by The Structured Interview for the Positive and Negative Syndrome Scaleanalyzed by a five-factor model. The Calgary Depression Scale for Schizophrenia was used to assess depression and suicidal ideation. Blood samples were analyzed for S-25(OH)D, CRP, sTNF-R1, IL-Ra and OPG. We performed bivariate correlations and multiple regression models to evaluate the effect of S-25(OH)D on the outcomes. Low S-25(OH)D was significantly associated with negative symptoms (adjusted R2=0.113, F(6,357)=8.58, p<0.001) and with depression (adjusted R2=0.045, F(4,357)=5.233, p<0.001) when adjusting for possible confounding factors (i.e. gender, education, diagnose, hospitalization status, ethnicity, season and thyroid status). CRP was correlated with both S-25(OH)D (rho=-0.13, p=0.02) and negative symptoms (rho=0.14, p=0.01), but did not act as a mediator. The correlations between S-25(OH)D and the inflammatory markers sTNF-R1, IL-Ra and OPG were not significant. There is a strong association between low S-25(OH)D and higher negative and depressive symptoms in psychotic disorders. Randomized controlled trials should be performed to investigate the effect of vitamin D supplementation as adjuvant treatment strategy in patients with prominent negative or depressive symptoms.

25 December 2022 in HERD: Health Environments Research & Design Journal
Verified
Journal Article
Open access
AFAnn Faerden
Ann Faerden
CRChristine Rosenqvist
Christine Rosenqvist
MHMats Håkansson
Mats Håkansson
ESEline Strøm-Gundersen
Eline Strøm-Gundersen
ÅSÅshild Stav
Åshild Stav
KKKaja Misvær Kistorp
Kaja Misvær Kistorp
Objectives: The goal of the current project was to enhance the feeling of dignity for patients in the seclusion unit in an acute psychiatric ward through environmental design changes and to evaluate the effect of the refurbishment. Background: Treating people with dignity is essential in all health-related work and important for our mental health. Hospital architecture and design signal values that can promote dignity. Patients who must spend time in seclusion are at their most vulnerable mental state and the often worn-down like environment can challenge the feeling of dignity. How environmental design can promote dignity in seclusion units have not been studied. Methods: To reach suggestions for design changes enhancing dignity, we used service design that included a broad user group. The effect of design changes was evaluated by a questionnaire answered by the nursing staff during a 4-week period pre- and post refurbishment and included a control group. Results: The design concepts agreed upon were a welcoming atmosphere, contact with nature, room for privacy, close contact with staff, and a designated smoking area inside the unit. The evaluation found that the environmental design changes significantly supported the patients in their situation and the staff in their work. Conclusion: We conclude that dignity design concepts are highly applicable also in an acute psychiatric setting and improve the situation of secluded mental health patients, which is much needed. Findings align with other environmental changes in psychiatric wards that improve the patients’ well-being and reduce aggression.